BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4367872)

  • 1. Effect of Al-chlorophenoxyisobutyrate (Alufibrate) on pyruvate metabolism and on the fate of very low density lipoprotein lipids in hyperlipidemic patients.
    Stähelin HB; Locher JT; Maier R
    Clin Chim Acta; 1974 Jul; 54(1):115-22. PubMed ID: 4367872
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of clofibrate on lipoprotein-lipids in patients with type IV hyperlipoproteinaemia (author's transl)].
    Weisweiler P; Schwandt P
    Klin Wochenschr; 1977 Aug; 55(16):791-4. PubMed ID: 198601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type III hyperlipoproteinemia: rise in high-density lipoprotein levels in response to therapy.
    Falko JM; Witztum JL; Schonfeld G; Weidman SW; Kolar JB
    Am J Med; 1979 Feb; 66(2):303-10. PubMed ID: 218451
    [No Abstract]   [Full Text] [Related]  

  • 4. [Proceedings: Effect of alufibrate (Atherolip) on pyruvate and lipoprotein metabolism in patients with hyperlipidemia type IV].
    Stähelin HB; Locher JT; Maier R
    Helv Med Acta; 1974 May; 37(5-6):388-9. PubMed ID: 4153233
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical and metabolic effects of pentaerythritol tetranicotinate in combination with cholesolvin or clofibrate.
    Olsson AG; Orö L; Rössner S
    Atherosclerosis; 1974; 19(3):407-15. PubMed ID: 4364073
    [No Abstract]   [Full Text] [Related]  

  • 6. Clofibrate and related compounds in hyperlipoproteinaemia. A review.
    Gustafson A
    Postgrad Med J; 1975; 51(8):suppl 66-71. PubMed ID: 215983
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of gemfibrozil and clofibrate on metabolism of cholesterol and plasma triglycerides in man.
    Kesäniemi YA; Grundy SM
    JAMA; 1984 May; 251(17):2241-6. PubMed ID: 6368883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of clofibrate, nicotinic acid and diet on the properties of the plasma lipoproteins in a subject with type III hyperlipoproteinemia.
    Patsch JR; Yeshurun D; Jackson RL; Gotto AM
    Am J Med; 1977 Dec; 63(6):1001-9. PubMed ID: 204188
    [No Abstract]   [Full Text] [Related]  

  • 9. [Familial hyperlipoproteinemia type III].
    Patsch JR; Patsch W; Sailer S; Braunsteiner H
    Dtsch Med Wochenschr; 1976 Oct; 101(44):1612-9. PubMed ID: 185039
    [No Abstract]   [Full Text] [Related]  

  • 10. Change of lipoprotein pattern by clofibrate in hyperglyceridaemia and mixed hyperlipidaemia.
    Miettinen TA; Penttilä IM; Lampainen E
    Acta Med Scand; 1972 Sep; 192(3):177-82. PubMed ID: 4341290
    [No Abstract]   [Full Text] [Related]  

  • 11. Xanthomatosis and hyperlipoproteinemia; a review.
    Polano MK
    Dermatologica; 1974; 149(1):1-9. PubMed ID: 4372111
    [No Abstract]   [Full Text] [Related]  

  • 12. Hyperlipoproteinemia type IV and pre-beta-lipoprotein. Some new aspects of its physiology, pathogenesis and diagnosis.
    Wille LE
    J Oslo City Hosp; 1972; 22(11):169-84. PubMed ID: 4344735
    [No Abstract]   [Full Text] [Related]  

  • 13. Metabolic relationships among the plasma lipoproteins. Reciprocal changes in the concentrations of very low and low density lipoproteins in man.
    Wilson DE; Lees RS
    J Clin Invest; 1972 May; 51(5):1051-7. PubMed ID: 4341500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The lipid hypothesis. Genetic basis.
    Glueck CJ; Kwiterovich PO
    Arch Surg; 1978 Jan; 113(1):35-41. PubMed ID: 202221
    [No Abstract]   [Full Text] [Related]  

  • 15. Familial hyperlipidemias. Diagnosis and treatment.
    Fleischmajer R; Dowlati Y; Reeves JR
    Arch Dermatol; 1974 Jul; 110(1):43-50. PubMed ID: 4371196
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypolipidaemic agents: What are they good for?
    Manninen V; Mälkönen M; Tuomilehto J
    Lancet; 1977 Dec; 2(8051):1281-2. PubMed ID: 73969
    [No Abstract]   [Full Text] [Related]  

  • 17. Clofibrate-induced low density liporotein elevation. Therapeutic implications and treatment by colestipol resin.
    Rose HG; Haft GK; Juliano J
    Atherosclerosis; 1976; 23(3):413-27. PubMed ID: 178325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum-lipoprotein-cholesterol distribution in healthy men with high serum-cholesterol concentrations: Extrapolation to clofibrate trial.
    Carlson LA; Olsson AG
    Lancet; 1979 Apr; 1(8121):869-70. PubMed ID: 86108
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of hyperlipidemia.
    Levy RI; Morganroth J; Rifkind BM
    N Engl J Med; 1974 Jun; 290(23):1295-301. PubMed ID: 4363888
    [No Abstract]   [Full Text] [Related]  

  • 20. Altering lipid patterns in adult males.
    Appelbaum JJ; Amundsen MA; Perkin DK
    J Occup Med; 1974 Aug; 16(8):539-42. PubMed ID: 4367267
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.